Celiac disease: clinical, endoscopic, and histopathologic review - 15/08/12
Doi : 10.1016/j.gie.2012.04.473
Lucinda A. Harris, MD 1, Jason Y. Park, MD, PhD 3, Lysandra Voltaggio, MD 4, Dora Lam-Himlin, MD 2, ⁎
1 Department of Gastroenterology, Mayo Clinic in Arizona, Scottsdale, Arizona
2 Department of Pathology, Mayo Clinic in Arizona, Scottsdale, Arizona
3 Department of Pathology, Children's Medical Center, and University of Texas Southwestern Medical Center, Dallas, Texas
4 Department of Pathology, George Washington University Hospital, Washington, DC, USA
Reprint requests: Dora Lam-Himlin, MD, Department of Pathology, Mayo Clinic in Arizona, 3400 East Shea Boulevard, Scottsdale, AZ 85259Abbreviations : tTG, DGP, EMA, HLA, IBS, IEL, IL, NSAID, RCD, VCE
Plan
| See CME section; p. 621. |
|
| DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: Dr Harris: consultant to Takeda and Ironwood/Forest Pharmaceuticals and consultant to and CME-sponsored speaker for Salix. The other authors disclosed no financial relationships relevant to this publication. |
© 2012
American Society for Gastrointestinal Endoscopy. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 76 - N° 3
P. 625-640 - septembre 2012 Retour au numéro
Article précédent
- Incorporating simulation into the GI curriculum: the time is now
- Robert E. Sedlack
- Percutaneous assisted transprosthetic endoscopic therapy (PATENT): expanding gut access to infinity and beyond! (with video)
- Todd H. Baron, Louis M. Wong Kee Song
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?